full of promise, page-41

re: full of promise/new info

i suspect their strategy initially will be to sell/partner the technology to established device suppliers to ultimately be incorporated into new generations of existing machines. Gets product to market quicker and the dollars flowing in ..

I think the emphesyma device is the killer application and as a diagnostic tool could result in mass screenings ... I think there would be big $'s there.

wonder if anyones seen a recent top20 shareholder statement for ordinaries and options?